PDS Biotechnology Corporation (NASDAQ:PDSB) Q2 2025 Earnings Call Transcript August 13, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results